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A B S T R A C T
Aim of this study was to investigate association of elevated body mass index and hypertension with general mortality in
the cohort from Croatian Adult Health Cohort Study (CroHort). Risk of death according to body mass index (BMI) and
blood pressure category, in period 2003/08, was calculated for 7,490 respondents, out of which 6,682 were alive and 808 were
dead in 2008. Among men aged 65 and more, elevated BMI was associated with lower risk of death, in accordance with
obesity paradox recorded in some previous studies which showed that older men with higher BMI have lower risk of death.
Among women aged 50–64 years, being hypertensive was associated with increased risk of death compared to normotensive
respondents. Despite obesity paradox which should be further explored, activities on primary and secondary prevention of
excess weight and hypertension should be encouraged as means to prevent premature mortality in Croatian population.
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Introduction
Cardiovascular diseases are the leading cause of death
in developed countries and are a rapidly growing cause of
death in low- and middle-income countries. According to
the Global Burden of Disease Study in 2002, the leading
cause of burden of disease in Europe are cardiovascular
diseases with a 23% share in all DALYs. Croatia has, ac-
cording to the same source, cardiovascular diseases at
the top of the list, with a proportion of 27% of all DALYs.
Over half of burden of disease are caused by seven
leading risk factors. The leading risk factor globally is
high blood pressure with a share of 12.8% and over-
weight is ranked 5th with a share of 7.8% in the DALY
burden. Among Croatians, elevated blood pressure is
ranked second (after smoking) with a share of 13.8%1.
In Croatia, ca. 50,000 people die annually. Mortality
rate is relatively stable at around 11‰. More than 50%
of all death causes are related to circulation diseases, due
to which 26,235 people died (591.2/100,000). The leading
diagnostic entities are ischemic heart disease and cere-
brovascular diseases (shares of 39% and 31% in circula-
tory disease group)2. Ischemic heart disease caused death
of 10,542 people (standardized rates: 157.75 / 100,000)
which ranked Croatia in European countries with me-
dium high mortality rates3.
High blood pressure and obesity are recognized as im-
portant risk factors for mortality all around the world4,5.
Each year more then 7 million people die as a result of
raised blood pressure and 2.6 million people as a result of
being overweight or obese6–8.
The studies based on the Croatian Health Survey 2003
data noted prevalence of arterial hypertension (therapy
administration or systolic pressure=140, or diastolic pres-
sure=90) of 45.6% for man and 43% for women9.
In Croatia, the prevalence of overweight and obesity
has been estimated at almost 60% of the adult popula-
tion10, and any association between overweight and mor-
tality might have important clinical and public health
implications. Overweight and obese people have an in-
creased risk of developing many serious conditions e.g.
cardiovascular disease11,12, diabetes mellitus13, certain
cancers14 like endometrial15, ovarian16, breast16,17, cervi-
cal16, prostate16,18, colorectal16,18, sleep apnea19.
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Aim of this study was to assess the association of ele-
vated body mass index and hypertension with general
mortality in the Croatian adult population cohort from
Croatian Adult Health Cohort Study (CroHort).
Sample and Methods
Sample
Respondents who participated in Croatian Adult Health
Survey 2003 (9,070 respondents) were contacted in 2008
in order to participate in the follow-up Croatian Adult
Health Cohort Study (CroHort). They were 18 years or
older at the time of the first survey. The contact was es-
tablished with 6,682 persons (73.7% of the original sam-
ple), out of which 3,229 agreed to participate in follow-up
survey (35.6%), while 3,453 persons refused (38.1%). For
808 persons (8.9% of the original sample) information
was obtained that they had died. Contact with remaining
1,580 persons (17.4%) was not established, meaning that
there was no information available whether they were
alive or not in 2008. Further details on this sample were
described elsewhere20.
Only persons for which information whether they
were alive in 2008 was available, were included in the
analysis encompassing total of 7,490 respondents (82.6%
of the original sample), out of which 6,682 were alive in
2008 and 808 were dead.
Variables
Public health nurses measured blood pressure in re-
spondents’ homes, while weight and height used to calcu-
late body mass index (BMI) were self-reported by respon-
dents and recorded on a questionnaire by public health
nurses. Blood pressure was measured twice during single
visit using a mercury sphygmomanometer, with respon-
dents seated for 20 minutes between the measurements.
Respondents whose BMI was lower than 25 kg/m2
were classified as normal weight, those whose BMI was
25 kg/m2 or higher, but lower than 30 kg/m2 were classi-
fied as overweight, while those whose BMI was 30 kg/m2
or higher were classified as obese.
Respondents who stated that they use anti-hyperten-
sive drugs or whose average blood pressure calculated
from two measurements was equal or higher than 140
mmHg for systolic or equal or higher than 90 mmHg for
diastolic blood pressure, were categorized as hypertensive.
Age of respondents used in analysis was from year
2003 and data about risk factors (BMI, hypertension)
were also from 2003 survey.
Statistical analysis
Percentage of respondents who died in period 2003–
2008 was calculated separately for men and women in
three main age groups (18–34 years, 35–64 years, 65
years and older) and in two additional age subgroups
(35–49 years, 50–64 years) for each BMI category: nor-
mal weight, overweight and obese as well as for both
blood pressure states: normotensive and hypertensive.
The multiple logistic regression analysis (adjusted for
age) was used to calculate OR for death in period 2003–
2008 depending on BMI (enrolled as continuous variable)
and presence of hypertension (enrolled as binary vari-
able: normotensive/hypertensive), separately for men and
women in each age group: 18–34 years, 35–49 years, 50–64
years, 65 years and older.
All confidence intervals (CI) were calculated with 95%
probability levels.
Statistical analysis was performed using SPSS (ver-
sion 14.01; License: Croatian National Institute of Public
Health).
Results
Both among men and women no significant differences
in percentage of respondents who died were recorded
among normal weight, overweight and obese respondents
in the age groups: 18–34 years and 35–64 years as well as
in the age subgroups: 35–49 years and 50–64 years, with
exception of overweight men who had significantly lower
percentage of respondents who died compared to those
with normal weight in the age group 35–64 years and with
exception of obese women who had significantly lower
percentage of respondents who died compared to over-
weight women in the age subgroup 35–49 years.
Among men aged 65 years and older, significantly
lower percentage of obese men died compared to normal
weight men, while no significant differences were re-
corded among women in that age group (Table 1).
Among men, no significant difference between nor-
motensive and hypertensive respondents in percentage
of those who died was recorded in any age group, while
among women aged 35–64 years percentage of hyperten-
sive respondents who died was significantly higher com-
pared to normotensive (Table 2).
For men, multiple logistic regression analysis showed
that being hypertensive was associated with increased
OR for death, while higher BMI was associated with
lower OR for death among respondents aged 65 years
and older. In younger age groups, neither BMI nor hyper-
tension were associated with significant difference in OR
for death.
For women, logistic regression analysis showed that
being hypertensive was associated with increased OR for
death among respondents aged 50–64 years, while nei-
ther BMI nor hypertension were associated with signifi-
cant difference in OR for death among other age groups
(Table 3).
Discussion
The results showed that being hypertensive was asso-
ciated with increased OR for death in man aged 65 years
and older and women aged 50–64 years. A correlation be-
tween mortality and high blood pressure has been widely
shown. Several studies have showed that the mortality
rate was higher among hypertensive adults than non hy-
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pertensive adults21–23. The public health significance of
hypertension results from the finding that it represents
an independent risk factor for cardiovascular diseases.
Progression of the hypertension is associated with vascu-
lar abnormalities that damage the heart, kidneys, brain
and other organs, and leads to premature morbidity and
death24–28.
Compared to normotensive individuals, people with an
elevated blood pressure have an increased tendency to have
other risk factors for CVD (i.e. diabetes, dyslipidemia)29.
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TABLE 1
NUMBER AND PERCENTAGE OF RESPONDENTS WHO DIED 2003–2008 ACCORDING TO THEIR WEIGHT IN 2003
Men Women
Characteristic Number % 95% CI Number % 95% CI
Age 18–34
normal weight (BMI< 25) 8 4.3 1.4–7.2 13 2.0 0.9–3.1
overweight (25 5 5.3 0.8–9.8 4 3.1 0.1–6.2
obese (BMI	30) 0 0.0 2 4.2 0.0–9.8
Age 35–64 total
normal weight (BMI< 25) 35 10.5 7.2–13.8 53 5.5 4.0–6.9
overweight (25BMI<30) 33 5.4 3.6–7.1 60 6.3 4.8–7.8
obese (BMI	30) 22 6.4 3.8–9.0 31 5.0 3.3–6.7
Age 35–49
normal weight (BMI< 25) 13 7.8 3.7–11.9 18 3.1 1.7–4.5
overweight (25BMI<30) 13 4.8 2.3–7.3 22 5.3 3.1–7.5
obese (BMI	30) 8 5.7 1.9–9.6 3 1.4 0.0–3.0
Age 50–64
normal weight (BMI< 25) 22 13.1 8.0–18.2 35 9.0 6.1–11.8
overweight (25BMI<30) 20 5.8 3.3–8.3 38 7.1 4.9–9.2
obese (BMI	30) 14 6.9 3.4–10.4 28 6.8 4.4–9.3
Age 65 and older
normal weight (BMI< 25) 79 31.2 25.5–36.9 123 24.6 20.9–28.4
overweight (25BMI<30) 91 23.6 19.3–27.8 129 18.5 15.6–21.4
obese (BMI	30) 25 15.4 9.9–21.0 93 18.4 15.0–21.8
TABLE 2
NUMBER AND PERCENTAGE OF RESPONDENTS WHO DIED 2003–2008 ACCORDING TO THEIR BLOOD PRESSURE IN 2003
Men Women
Characteristic Number % 95% CI Number % 95% CI
Age 18–34
normotensive 9 3.6 1.3–5.9 19 2.5 1.4–3.7
hypertensive 4 6.3 0.3–12.4 0 0.0
Age 35–64 total
normotensive 45 7.4 5.3–9.5 60 4.3 3.3–5.4
hypertensive 45 6.5 4.7–8.4 85 7.3 5.8–8.8
Age 35–49
normotensive 23 6.9 4.2–9.6 32 3.7 2.4–4.9
hypertensive 11 4.5 1.9–7.1 12 3.5 1.6–5.5
Age 50–64
normotensive 22 8.1 4.8–11.3 28 5.4 3.5–7.4
hypertensive 34 7.6 5.2–10.1 73 8.8 6.9–10.8
Age 65 and older
normotensive 38 19.0 13.6–24.4 60 17.9 13.8–22.0
hypertensive 157 26.0 22.5–29.5 286 20.9 18.8–23.1
Systolic and diastolic blood pressure tends to rise with
age and prevalence of hypertension increases after the
age of 50 years. Some population studies have showed
positive relationship between blood pressure and mortal-
ity at the age of 60–69 years, less in age group 75 years
and older, but negative relationship in older than 85
years. This negative relationship in very elderly is proba-
bly caused by terminal phase of cardiac, respiratory and
neoplastic disease and consequent low blood pressure30.
Analysis showed that in the age group 35–64 years
significantly lower percentage of respondents died among
overweight men compared to those with normal weight
and in the age subgroup 35–49 years significantly lower
percentage of respondents died among obese women
compared to overweight women. Among men aged 65
years and older, higher BMI was associated with lower
OR for death.
In several studies overweight and obesity are associ-
ated with increased all-cause mortality and showed an
optimal BMI of 22.5 to 25.0 in analyses of all study parti-
cipants31–33.
Obesity has been clearly identified as a risk for pre-
mature death34–36, but the most studies recorded vari-
ability in the association of overweight and mortality.
Flegal et al., Heather M.Orpana et al. and other authors
found that underweight and obesity (particularly higher
levels of obesity) were clear risk factors for mortality, but
overweight was associated with a significantly decreased
risk of death37–39.
Association between elevated body weight and excess
deaths is not necessarily causal. Many factors influence
mortality risk in addition to higher BMI. The reason for
variability among studies assessing the association of
BMI and mortality was that they had a different length
of follow-up and inadequate control for confounder that
might mask association of BMI with mortality40. This
study has a short follow-up and it is possible that the pat-
tern of results could change during a longer period of fol-
low-up. The relation between BMI and all causes death
differed according to smoking status, pre-existing chro-
nic diseases and weight loss due to disease which may or
may not be recognizable clinically38,41–44.
Due to the concern that pre-existing disease could in-
fluence the association between BMI and mortality, our
analyses were also adjusted for hypertension, but not for
other chronic diseases.
Smoking is an important confounder because people
who smoke generally have a lower body mass index than
non-smokers41,45.
People who smoke have a higher risk of death due to
cardiovascular diseases (heart attack and stroke, periph-
eral vascular disease), chronic obstructive pulmonary
diseases or cancer and low weight or weight loss may be
in relationships with ill health. When assessing the rela-
tionship between body weight and mortality, it is impor-
tant to taking smoking status and pre-existing disease
into account46,47.
In the general population, obesity is associated with
increased risk of adverse outcomes. Studies of patients
with chronic disease suggest that overweight and obese
patients may paradoxically have lower risk of death com-
pared with those with normal weight. Pre-existing ill-
ness could lead to lower BMI and earlier mortality43,47,48.
In most reviewed studies, optimal BMI was associated
with the lowest mortality increase with age and higher
weight is not often associated with poor health49–53.
The results of this research support the obesity para-
dox presence in the elderly. They showed that being
obese is a protective factor for death in men aged 65
years and older. Elderly with low BMI or weight loss may
have chronic disease, co-morbidity and unrecognized ill-
ness which can be associated with higher mortality ra-
tes54. In most populations, the body-mass index is corre-
lated with more direct measures of body fat, but in el-
derly it may be a less useful indicator of adiposity. BMI
may be relatively low among older people who have little
muscle mass compared to adipose tissue and who tend to
have a shift of fat from peripheral to central sites without
increase in body-mass index55.
Many factors influence body weight and additional re-
search to confirm association between BMI and mortal-
ity in different age groups would be of interest.
Excess body weight and hypertension are strong de-
terminants as well as modifiable risk factors for all-cause
mortality, and as such carry the potential for primary
prevention. Despite variability in association of over-
weight and mortality among different age groups, a re-
view of the literature provides much support for public
health messages that advocate the benefit of change to
healthier lifestyle regardless of age, in order to prevent
excess body weight and hypertension as well as associ-
ated premature mortality.
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TABLE 3
ASSOCIATION OF BMI AND HYPERTENSION WITH RISK OF
DEATH IN PERIOD 2003–2008
Men Women
Characteristic OR* 95% CI OR* 95% CI
Age 18–34
BMI 0.93 0.79–1.10 1.09 0.98–1.22
hypertension 2.08 0.59–7.32 0.00
Age 35–49
BMI 0.97 0.90–1.06 1.02 0.96–1.10
hypertension 0.67 0.31–1.45 0.87 0.42–1.79
Age 50–64
BMI 0.93 0.87–1.00 0.97 0.93–1.02
hypertension 1.10 0.62–1.97 1.65 1.03–2.65
Age 65 and older
BMI 0.93 0.89–0.98 0.99 0.96–1.01
hypertension 1.53 1.01–2.30 1.25 0.91–1.72
* adjusted for age
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POVEZANOST POVE]ANOG INDEKSA TJELESNE MASE I HIPERTENZIJE S MORTALITETOM
U HRVATSKOJ KOHORTNOJ STUDIJI KARDIOVASKULARNOG ZDRAVLJA 2003/08
S A @ E T A K
Cilj ovog rada bio je istra`iti povezanost pove}anog indeksa tjelesne mase (ITM) i hipertenzije s op}im mortalitetom
u kohorti ispitanika Hrvatske kohortne studije kardiovaskularnog zdravlja 2003/08. Rizik od smrti prema kategorijama
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indeksa tjelesne mase i krvnog tlaka, u razdoblju 2003–08. godine, izra~unat je za 7,490 ispitanika, od kojih je u 2008.
godini bilo 6,682 `ivih i 808 mrtvih. Kod mu{karaca u dobi od 65 i vi{e godina, pove}an ITM bio je povezan s manjim
rizikom od smrti u skladu s paradoksom debljine zabilje`enim u nekim prethodnim studijama koje su pokazale sa stariji
mu{karci vi{im ITM imaju manji rizik od smrti. Kod `ena u dobi 50–64 godine, prisutnost hipertenzije bila je povezana
s pove}anim rizikom od smrti u usporedbi s ispitanicama s normalnim krvnim tlakom. Usprkos paradoksu debljine koji
tra`i daljnja istra`ivanja, potrebno je poticati aktivnosti u primarnoj i sekundarnoj prevenciji prekomjerne tjelesne
te`ine i hipertenzije kao sredstvima za sprje~avanje prerane smrtnosti u hrvatskom stanovni{tvu.
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